Introduction Bronchiolitis, a viral lower respiratory tract infection, is the leading cause of hospitalisation for infants, with healthcare utilisation highest among young infants (aged ≤90 days).

Liver diseases remain clinically challenging and exhibit complex cellular interactions, including liver cell–immune cell communications that can shape disease progression.1 During portal injury, ...

Introduction Tocilizumab improves outcomes in critically ill patients with COVID-19. Whether other immune-modulator strategies are equally effective or better is unknown. Methods We investigated ...

Introduction Homelessness across the early life course poses a grave and largely preventable challenge. Those who experience homelessness early are at increased risk of a range of health, education ...

2 Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China Background Integration of large proteomics and genetic data in population-based studies can provide ...

Background To evaluate the efficacy of rituximab in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients not responding to conventional immune therapies. Methods An open-label, ...

Correspondence to Dr Tareq Kass-Hout, Department of Neurology, University of Chicago College, Chicago, Illinois, USA; tkasshout{at}bsd.uchicago.edu Background The transradial approach (TRA) for ...

Background Phosphorylated-tau181 (p-tau181), a specific marker of Alzheimer’s disease (AD) pathology, was found elevated in plasma but not in cerebrospinal fluid (CSF) of patients with amyotrophic ...

Correspondence to Dr Kerstin Welén Schef, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm 171 77, Sweden; kerstin.welen-schef{at}ki.se Objective To assess the ...

1 Chronic Disease Epidemiology Research Center, Department of Preventive Medicine, Universidade Federal de São Paulo, São Paulo, Brazil 2 Center for Epidemiological Studies in Health and Nutrition, ...